Ban on foreigners arriving from Bangladesh, Nepal, Pakistan

Ban on foreigners arriving from Bangladesh, Nepal, Pakistan

Thailand has now closed its border to foreigners travelling from India, Bangladesh, Nepal and Pakistan. (Bangkok Post photo)
Thailand has now closed its border to foreigners travelling from India, Bangladesh, Nepal and Pakistan. (Bangkok Post photo)

Thailand has closed its border to foreign travellers arriving from three more countries in the Indian subcontinent on the back of the first confirmed cases of the Indian variant of Covid-19 in the country.

There has been a ban on foreigners coming from India entering Thailand since May 1.

Foreign Ministry spokesman Tanee Sangrat said on Monday the Thai embassies in Bangladesh, Nepal and Pakistan had now also stopped issuing certificates of entry for non-Thai nationals, from May 10 until further notice.

Thai nationals were still allowed to apply for the document, which is needed to return to Thailand during the epidemic, he said.

The ban followed the detection of the Indian variant, coded B.1.617.1, in a Thai woman and her son who arrived from Pakistan, announced by the Centre for Covid-19 Situation Administration on Monday.

The CCSA had indicated earlier on Monday, during its daily briefing, that entry would be banned from three more countries amid concerns of more cases of the Indian variant.

A certificate of entry is currently compulsory for all people wanting to come to the kingdom.

Do you like the content of this article?
COMMENT (16)

Here to stay

Gen Prayut Chan-o-cha says he will serve his full term as prime minister, ending speculation he may dissolve the House and call a fresh election before his term ends in 2023.

14 Jun 2021

Man with 39 wives dies in India

NEW DELHI: A 76-year-old man who had 39 wives and 94 children and was said to be the head of the world's largest family has died in northeast India, the chief minister of his home state said.

14 Jun 2021

Novavax vaccine more than 90% effective in US trial

Novavax Inc on Monday reported late-stage data from its US-based clinical trial showing its vaccine is more than 90% effective against Covid-19 across a variety of variants of the virus.

14 Jun 2021